Division of Vascular Surgery and Endovascular Therapy, University of Colorado Anschutz School of Medicine, Aurora, CO.
University of Colorado Anschutz School of Medicine, Aurora, CO.
Ann Vasc Surg. 2023 May;92:49-56. doi: 10.1016/j.avsg.2023.01.016. Epub 2023 Feb 1.
The reported risk of a cranial nerve (CN) injury is up to 1 in 4 patients in large registries of carotid body tumor (CBT) resection. Functional outcome for this population is unknown.
We evaluated consecutive patients who underwent CBT resection from November 2013 through October 2020. Demographics, intraoperative details, complications, and outcomes were recorded from the medical record. Permanent CN nerve injury was defined as deficits lasting >6 months. Frequency statistics, averages, chi-squared test, and multiple logistic regression were completed for primary end points of complications and disease-free survival. Patient-reported outcomes were gathered via telephone survey of patients conducted in September 2021.
Fifty-one patients presented with CBTs and the following Shamblin classes: I (n = 7; 14%), II (n = 36; 69%), and III (n = 9; 17%). Head and neck oncology and vascular surgery jointly did 52% of CBT resections, including 6 of 9 Shamblin III cases. Eight patients (15.3%, all Shamblin II or III) suffered a total of 12 CN injuries - 8 CN XII (5 temporary and 3 permanent), 3 CN X (all permanent), and 1 CN XI (permanent). Seven of the CN injury subgroup had preoperative embolization and 5 were joint oncology/vascular cases. In addition, 4 separate carotid injuries required repair. Notably, all patients had disease-free survival postoperatively at a mean follow-up of 6 months. Patient-reported outcomes obtained in 70.6% of patients 1 year or more from index operation demonstrated that two-thirds of patients live without any permanent functional deficits, and the majority of those with continued deficits rate the symptoms as daily but mild in severity.
In a series of complex CBT patients treated with preoperative embolization capabilities and multidisciplinary surgical approach, disease-free survival was achieved in all patients despite a high rate of iatrogenic CN injuries, most commonly CN XII. Patient-reported outcomes survey results indicate that injuries identified on clinical exam underreport patients' true postoperative CN deficits - especially branches of CN X. This data support the practice of aggressive primary resection of CBTs while providing guidance for expected functional outcomes due to CN injury risk.
在大型颈动脉体瘤(CBT)切除术登记处,多达 1/4 的患者报告存在颅神经(CN)损伤风险。该人群的功能预后尚不清楚。
我们评估了 2013 年 11 月至 2020 年 10 月连续接受 CBT 切除术的患者。从中位病历中记录患者的人口统计学资料、术中细节、并发症和结局。永久性 CN 神经损伤的定义为持续超过 6 个月的缺陷。主要终点为并发症和无病生存率,采用频率统计、平均值、卡方检验和多元逻辑回归进行分析。2021 年 9 月通过电话调查患者收集患者报告的结果。
51 例患者出现 CBT,Shamblin 分级如下:I 级(n=7;14%)、II 级(n=36;69%)和 III 级(n=9;17%)。头颈肿瘤学和血管外科学联合完成了 52%的 CBT 切除术,包括 9 例 III 级 Shamblin 病例中的 6 例。8 例患者(15.3%,均为 II 级或 III 级)共发生 12 例 CN 损伤-8 例 CN XII(5 例为暂时性,3 例为永久性)、3 例 CN X(均为永久性)和 1 例 CN XI(永久性)。7 例 CN 损伤亚组患者术前接受了栓塞治疗,5 例为联合肿瘤/血管病例。此外,有 4 例颈动脉单独受伤需要修复。值得注意的是,所有患者在术后平均 6 个月的随访中均无疾病生存。对指数手术后 1 年或以上的 70.6%患者进行的患者报告结果显示,三分之二的患者无任何永久性功能缺陷,大多数有持续缺陷的患者将症状描述为日常但轻度。
在一系列接受术前栓塞能力和多学科手术方法治疗的复杂 CBT 患者中,所有患者均实现了无疾病生存,尽管发生了高发生率的医源性 CN 损伤,最常见的是 CN XII。患者报告的结果调查结果表明,临床检查中确定的损伤报告低估了患者术后真实的 CN 缺陷-尤其是 CN X 的分支。这些数据支持积极进行 CBT 原发性切除术的实践,同时为由于 CN 损伤风险而导致的预期功能结局提供指导。